help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stokes Peebles, R.
Right arrow Articles by Sheller, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stokes Peebles, R., Jr.
Right arrow Articles by Sheller, J. R.

Am. J. Respir. Crit. Care Med., Volume 165, Number 8, April 2002, 1154-1160

Selective Cyclooxygenase-1 and -2 Inhibitors Each Increase Allergic Inflammation and Airway Hyperresponsiveness in Mice

R. Stokes Peebles Jr., Koichi Hashimoto, Jason D. Morrow, Ryszard Dworski, Robert D. Collins, Yuko Hashimoto, John W. Christman, Kyung-Ho Kang, Kasia Jarzecka, Jamye Furlong, Daphne B. Mitchell, Megha Talati, Barney S. Graham, and James R. Sheller

Department of Medicine and Department of Pathology, Vanderbilt University School of Medicine, Nashville, Tennessee; and Vaccine Research Center, National Institutes of Health, Bethesda, Maryland

Nonselective cyclooxygenase (COX) inhibition during allergic sensitization with ovalbumin in a murine model leads to an increase in the Type 2 cytokines interleukin-5 (IL-5) and IL-13; however, the effect of selective COX-1 and COX-2 inhibitors on these cytokines is unknown. We found that COX-1 protein was constitutively expressed in lung tissue. Expression of COX-1 protein did not increase with ovalbumin sensitization, but expression of COX-2 protein did. Ovalbumin-sensitized mice treated with either selective COX-1 inhibitor SC58560 (OVA-COX-1 inhibitor) or selective COX-2 inhibitor SC58236 (OVA-COX-2 inhibitor) had significantly greater airway hyperresponsiveness (p < 0.05) and higher levels of IL-13 (p < 0.05) in lung supernatants than did untreated mice that were ovalbumin sensitized (OVA). Lung mRNA levels for the chemokine receptors CCR1 through CCR5 (expressed on eosinophils, basophils, lymphocytes, and dendritic cells) were increased in the OVA-COX-2 inhibitor and OVA-indomethacin groups. We conclude that in the BALB/c mouse, COX inhibition with either a COX-1 or COX-2 inhibitor during allergen sensitization augments production of IL-13 and increases airway hyperresponsiveness.




This article has been cited by other articles:


Home page
 Eur Respir JHome page
L. Swedin, T. Neimert-Andersson, J. Hjoberg, S. Jonasson, M. van Hage, M. Adner, A. Ryrfeldt, and S-E. Dahlen
Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged mice
Eur. Respir. J., July 1, 2009; 34(1): 200 - 208.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. M. Sturm, P. Schratl, R. Schuligoi, V. Konya, G. J. Sturm, I. Th. Lippe, B. A. Peskar, and A. Heinemann
Prostaglandin E2 Inhibits Eosinophil Trafficking through E-Prostanoid 2 Receptors
J. Immunol., November 15, 2008; 181(10): 7273 - 7283.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
W. Zhou, D. C. Newcomb, M. L. Moore, K. Goleniewska, J. F. O'Neal, and R. S. Peebles Jr.
Cyclooxygenase Inhibition during Allergic Sensitization Increases STAT6-Independent Primary and Memory Th2 Responses
J. Immunol., October 15, 2008; 181(8): 5360 - 5367.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. J. Yoon, S.-B. Jeon, I.-H. Kim, and E. J. Park
Regulation of TLR2 Expression by Prostaglandins in Brain Glia
J. Immunol., June 15, 2008; 180(12): 8400 - 8409.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
L. Wang, V. Pozzato, G. Turato, A. Madamanchi, T. M. Murphy, and P. Chitano
Reduced spontaneous relaxation in immature guinea pig airway smooth muscle is associated with increased prostanoid release
Am J Physiol Lung Cell Mol Physiol, May 1, 2008; 294(5): L964 - L973.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
H. Hammad, M. Kool, T. Soullie, S. Narumiya, F. Trottein, H. C. Hoogsteden, and B. N. Lambrecht
Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells
J. Exp. Med., February 19, 2007; 204(2): 357 - 367.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
C. Bonnans and B. D. Levy
Lipid Mediators as Agonists for the Resolution of Acute Lung Inflammation and Injury
Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 201 - 205.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
W. Zhou, K. Hashimoto, K. Goleniewska, J. F. O'Neal, S. Ji, T. S. Blackwell, G. A. FitzGerald, K. M. Egan, M. W. Geraci, and R. S. Peebles Jr.
Prostaglandin I2 Analogs Inhibit Proinflammatory Cytokine Production and T Cell Stimulatory Function of Dendritic Cells
J. Immunol., January 15, 2007; 178(2): 702 - 710.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
P. Nieri, C. Martinelli, C. Blandizzi, N. Bernardini, R. Greco, C. Ippolito, M. Del Tacca, and M. C. Breschi
Role of Cyclooxygenase Isoforms and Nitric-Oxide Synthase in the Modulation of Tracheal Motor Responsiveness in Normal and Antigen-Sensitized Guinea Pigs
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 648 - 656.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. W. Card, M. A. Carey, J. A. Bradbury, J. P. Graves, F. B. Lih, M. P. Moorman, D. L. Morgan, L. M. DeGraff, Y. Zhao, J. F. Foley, et al.
Cyclooxygenase-1 Overexpression Decreases Basal Airway Responsiveness but Not Allergic Inflammation
J. Immunol., October 1, 2006; 177(7): 4785 - 4793.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
G. Y. Park and J. W. Christman
Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases
Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L797 - L805.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. Feng, E. M. Beller, S. Bagga, and J. A. Boyce
Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses
Blood, April 15, 2006; 107(8): 3243 - 3250.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. J. Loza, S. Foster, S. P. Peters, and R. B. Penn
Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells
Blood, March 1, 2006; 107(5): 2052 - 2060.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. S. Peebles Jr, K. Hashimoto, J. R. Sheller, M. L. Moore, J. D. Morrow, S. Ji, J. A. Elias, K. Goleniewska, J. O'Neal, D. B. Mitchell, et al.
Allergen-Induced Airway Hyperresponsiveness Mediated by Cyclooxygenase Inhibition Is Not Dependent on 5-Lipoxygenase or IL-5, but Is IL-13 Dependent
J. Immunol., December 15, 2005; 175(12): 8253 - 8259.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
P Montuschi, F Macagno, P Parente, S Valente, L Lauriola, G Ciappi, S A Kharitonov, P J Barnes, and G Ciabattoni
Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD
Thorax, October 1, 2005; 60(10): 827 - 833.
[Abstract] [Full Text] [PDF]

Home page
 Sci SignalHome page
K. F. Chung
Evaluation of Selective Prostaglandin E2 (PGE2) Receptor Agonists as Therapeutic Agents for the Treatment of Asthma
Sci. Signal., September 27, 2005; 2005(303): pe47 - pe47.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Hashimoto, J. R. Sheller, J. D. Morrow, R. D. Collins, K. Goleniewska, J. O'Neal, W. Zhou, S. Ji, D. B. Mitchell, B. S. Graham, et al.
Cyclooxygenase Inhibition Augments Allergic Inflammation through CD4-Dependent, STAT6-Independent Mechanisms
J. Immunol., January 1, 2005; 174(1): 525 - 532.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S.-H. Chang, C. H. Liu, R. Conway, D. K. Han, K. Nithipatikom, O. C. Trifan, T. F. Lane, and T. Hla
From the Cover: Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression
PNAS, January 13, 2004; 101(2): 591 - 596.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. A. Carey, D. R. Germolec, J. A. Bradbury, R. A. Gooch, M. P. Moorman, G. P. Flake, R. Langenbach, and D. C. Zeldin
Accentuated T Helper Type 2 Airway Response after Allergen Challenge in Cyclooxygenase-1-/- but Not Cyclooxygenase-2-/- Mice
Am. J. Respir. Crit. Care Med., June 1, 2003; 167(11): 1509 - 1515.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K.-i. Inoue, H. Takano, Y. Kawahito, H. Sano, T. Yoshikawa, M. Hinojosa, and C. Martin-Garcia
Cyclooxygenase-2 Inhibitors in Aspirin-Induced Asthma
Chest, April 1, 2003; 123(4): 1317 - 1318.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Asthma, Airway Biology, and Nasal Disorders in AJRCCM 2002
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 319 - 332.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Harizi, M. Juzan, J.-F. Moreau, and N. Gualde
Prostaglandins Inhibit 5-Lipoxygenase-Activating Protein Expression and Leukotriene B4 Production from Dendritic Cells Via an IL-10-Dependent Mechanism
J. Immunol., January 1, 2003; 170(1): 139 - 146.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Peters-Golden
Open Mind, Open Airways . Broadening the Paradigm of Prostaglandins and Allergic Airway Inflammation
Am. J. Respir. Crit. Care Med., April 15, 2002; 165(8): 1035 - 1036.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2002 American Thoracic Society 		  ATS Quiz on Sleep Study Tracings